Cardiogenic shock: Single center experience with and without on-site catheterization facilities

Cardiology

Volumn 93, Issue 1-2, 2000, Pages 87-92

  Barbash, Israel M ^a   Ilia, Reuben ^a   Gilutz, Harel ^a   Boyko, Valentina ^c   Battler, Alexander ^b   Leor, Jonathan ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cardiogenic shock; Heart failure; Myocardial infarction; Percutaneous transluminal coronary angioplasty

Indexed keywords

AGED; ANGIOCARDIOGRAPHY; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; LABORATORY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0033923639     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007007     Document Type: Article

References (14)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM: Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999;340:1162-1168.
2. Lee L, Bates ER, Pitt B, Walton JA, Laufer N, O'Neill WW: Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78:1145-1351.
3. Gacioch GM, Ellis SG, Lee L, Bales ER, Kirsh M, Walton JA, Topol EJ: Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992;19:647-653.
4. Eltchaninoff H, Simpfendorfer C, Franco I, Raymond RE, Casale PN, Whitlow PL: Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: A retrospective study comparing coronary angioplasty with medical treatment. Am Heart J 1995;130:459-464.
5. Berger PB, Holmes DR, Stebbins AL, Bates ER, Califf RM, Topol EJ, for the GUSTO-I Investigators: Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. Circulation 1997;96:122-127.
6. Urban P, Stauffer JC, Bleed D, Khatchatrian N, Amann W, Bertel O, van den Brand M, Danchin N, Kaufmann U, Meier B, Machecourt J, Pfisterer M: A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH. Eur Heart J 1999;20:1030-1038.
7. Himbert D, Juliard JM, Steg PG, Karrillon GJ, Aumont MC, Gourgon R: Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction. Am J Cardiol 1994;74:492-494.
8. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH: Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock? N Engl J Med 1999;341: 625-634.
9. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley JD, McKinlay S, Sanborn T, LeJemtel T, and the SHOCK Registry Investigators: Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an international registry. SHOCK Registry Investigators. Circulation 1995;91:873-881.
10. Holmes DR Jr, Califf RM, Van de Werf F, Berger PB, Bates ER, Simoons ML, White HD, Thompson TD, Topol EJ, for the GUSTO-I Investigators: Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: Results from the GUSTO trial. Lancet 1997;349:75-78.
11. Hasdai D, Holmes DR Jr, Topol EJ, Berger PB, Criger DA, Hochman JS, Bates ER, Vahanian A, Armstrong PW, Wilcox R, Ohman EM, Califf RM: Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global use of strategies to open occluded coronary arteries. Eur Heart J 1999;20:128-135.
12. Perez-Castellano N, Garcia E, Serrano JA, Elizaga J, Soriano J, Abeytua M, Botas J, Rubio R, Lopez de Sa E, Lopez-Sendon JL, Delcan JL: Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 1999; 83:989-993.
13. Hollenberg SM, Kavinsky CJ, Parrillo JE: Cardiogenic shock. Ann Intern Med 1999;131:47-59.
14. Beyersdorf F, Acar C, Buckberg GD, Partington MT, Okamoto F, Allen BS, Young HH, Bugyi HI: Studies on prolonged acute regional ischemia. V. Metabolic support of remote myocardium during left ventricular power failure. J Thorac Cardiovasc Surg 1989;98:567-579.